Robert Lilley

Chairman at Immunexpress

40 years’ experience - SVP, Global Sales & Marketing for Digene Corp from IPO to acquisition by QIAGEN NV (in 2007) creating market & technology leader in molecular Dx. Then, Senior Advisor/Molecular Diagnostics for Developing World at QIAGEN. Consultant to John D Rockefeller 3rd Fund, 23andMe, ImpediMed Pty Ltd, Vertex Pharma, OpGen.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Immunexpress

Immunexpress Pty Ltd, a molecular diagnostics company, develops clinical assays for the management of immune disorders.


Employees

11-50

Links